{"title":"sage指南委员会","authors":"J. F. Botha","doi":"10.4314/SAGR.V5I3.30742","DOIUrl":null,"url":null,"abstract":"Chronic hepatitis B virus infection remains a global problem of staggering proportions. It is estimated that 350 million people worldwide are chronically infected with the hepatitis B virus (HBV) and sub-Saharan Africa remains a high prevalence region. Most carriers will not develop significant hepatic disease but 15 - 40 % will develop serious sequelae during their lifetime.","PeriodicalId":39144,"journal":{"name":"South African Gastroenterology Review","volume":"5 1","pages":"30-31"},"PeriodicalIF":0.0000,"publicationDate":"2008-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"40","resultStr":"{\"title\":\"SAGES Guidelines Committee\",\"authors\":\"J. F. Botha\",\"doi\":\"10.4314/SAGR.V5I3.30742\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chronic hepatitis B virus infection remains a global problem of staggering proportions. It is estimated that 350 million people worldwide are chronically infected with the hepatitis B virus (HBV) and sub-Saharan Africa remains a high prevalence region. Most carriers will not develop significant hepatic disease but 15 - 40 % will develop serious sequelae during their lifetime.\",\"PeriodicalId\":39144,\"journal\":{\"name\":\"South African Gastroenterology Review\",\"volume\":\"5 1\",\"pages\":\"30-31\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-01-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"40\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South African Gastroenterology Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4314/SAGR.V5I3.30742\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African Gastroenterology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/SAGR.V5I3.30742","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Chronic hepatitis B virus infection remains a global problem of staggering proportions. It is estimated that 350 million people worldwide are chronically infected with the hepatitis B virus (HBV) and sub-Saharan Africa remains a high prevalence region. Most carriers will not develop significant hepatic disease but 15 - 40 % will develop serious sequelae during their lifetime.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
